In conclusion, our findings demonstrate that CSRNP1 functions as a tumor suppressor in HCC, exerting its anti-tumor effects through the ROS-dependent activation of the JNK/p38 MAPK signaling pathway. This evidence concerns the gene CSRNP1 and hepatocellular carcinoma.